Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC0Morbidity and Mortality Weekly Report

Use of Glucagon-Like Peptide-1 Medications and Modified Medication Use Among Adults — United States, 2025

  1. 1Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, CDC; U.S. Public Health Service, Rockville, Maryland.

Related

  1. Hope, hype, and high costs: Navigating glucagon-like Peptide-1 based therapy initiation among young adults
    Sourav Das Gupta, Jaqueline Krystel Loubeau, Antara Swarnali Priyanka +5
    Obesity pillarsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Association of Glucagon-like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors with Tuberculosis and Mortality in Adults with Diabetes
    Chun-Hsiang Hsu, Renin Chang, Chiu-Fan Chen +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMC
  3. De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
    Wares Jalil
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
    Alaa Solaiman Algazzar
    Saudi Journal of Internal MedicinePeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismDOAJ
  5. Glucagon-like peptide-1 secretagogues from the leaves of Oparanthus teikiteetinii
    Clément Huguet, Opeyemi Joshua Olatunji, Eleonore Real +2
    Phytochemistry LettersPeer-reviewedPublisher termsFull text2 citedGeneral biologyPharmacology & toxicologyHAL
BibTeX
@article{pierce2026glucagonlike,
  title = {{Use of Glucagon-Like Peptide-1 Medications and Modified Medication Use Among Adults — United States, 2025}},
  author = {Samantha L. Pierce and Lilanthi Balasuriya and Lyudmyla Kompaniyets and Alyson B. Goodman},
  journal = {Morbidity and Mortality Weekly Report},
  year = {2026},
  month = nov,
  doi = {10.15585/mmwr.mm7544a1},
  url = {https://doi.org/10.15585/mmwr.mm7544a1},
  note = {CC0},
}
RIS
TY  - JOUR
TI  - Use of Glucagon-Like Peptide-1 Medications and Modified Medication Use Among Adults — United States, 2025
AU  - Samantha L. Pierce
AU  - Lilanthi Balasuriya
AU  - Lyudmyla Kompaniyets
AU  - Alyson B. Goodman
PY  - 2026
DA  - 2026/11/12
JO  - Morbidity and Mortality Weekly Report
DO  - 10.15585/mmwr.mm7544a1
UR  - https://doi.org/10.15585/mmwr.mm7544a1
SN  - 0149-2195
SN  - 1545-861X
ER  -